Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Peer

Showing results (151-160 of 181) with videos related to

Pageof 19
Sort By:
ACS Nano|January 22, 2021
Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered <i>via</i> Lipid NanoparticlesUri Elia, Srinivas Ramishetti, Ronit Rosenfeld, et al.
Biomedical Microdevices|April 8, 2019
A tissue chamber chip for assessing nanoparticle mobility in the extravascular spaceValeria Lusi, Thomas L Moore, Federica Laurino, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2011
Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune responseShoshy Mizrahy, Sabina Rebe Raz, Martin Hasgaard, et al.
Science Advances|November 19, 2020
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapyDaniel Rosenblum, Anna Gutkin, Ranit Kedmi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2025
Novel Bivalent mRNA-LNP Vaccine for Highly Effective Protection against Pneumonic PlagueUri Elia, Yinon Levy, Hila Cohen, et al.
Nature Communications|August 18, 2025
Targeting intestinal inflammation using locked nucleic acids delivered via lipid nanoparticlesShahd Qassem, Gonna Somu Naidu, Meir Goldsmith, et al.
Bioconjugate Chemistry|January 3, 2017
Comprehensive and Systematic Analysis of the Immunocompatibility of Polyelectrolyte CapsulesMikhail V Zyuzin, Paula Díez, Meir Goldsmith, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2015
Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignanciesShiri Weinstein, Itai A Toker, Rafi Emmanuel, et al.
Nature Nanotechnology|January 31, 2018
A modular platform for targeted RNAi therapeuticsRanit Kedmi, Nuphar Veiga, Srinivas Ramishetti, et al.
Small (Weinheim an Der Bergstrasse, Germany)|June 23, 2025
On-Chip De Novo Production of mRNA Vaccine in Lipid NanoparticlesShai Zilberzwige-Tal, Aviad Levin, Assaf Ezra, et al.
Pageof 19

Showing results (151-160 of 181) with videos related to

Sort By:
Pageof 19
ACS Nano|January 22, 2021
Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered <i>via</i> Lipid NanoparticlesUri Elia, Srinivas Ramishetti, Ronit Rosenfeld, et al.
Biomedical Microdevices|April 8, 2019
A tissue chamber chip for assessing nanoparticle mobility in the extravascular spaceValeria Lusi, Thomas L Moore, Federica Laurino, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2011
Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune responseShoshy Mizrahy, Sabina Rebe Raz, Martin Hasgaard, et al.
Science Advances|November 19, 2020
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapyDaniel Rosenblum, Anna Gutkin, Ranit Kedmi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2025
Novel Bivalent mRNA-LNP Vaccine for Highly Effective Protection against Pneumonic PlagueUri Elia, Yinon Levy, Hila Cohen, et al.
Nature Communications|August 18, 2025
Targeting intestinal inflammation using locked nucleic acids delivered via lipid nanoparticlesShahd Qassem, Gonna Somu Naidu, Meir Goldsmith, et al.
Bioconjugate Chemistry|January 3, 2017
Comprehensive and Systematic Analysis of the Immunocompatibility of Polyelectrolyte CapsulesMikhail V Zyuzin, Paula Díez, Meir Goldsmith, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2015
Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignanciesShiri Weinstein, Itai A Toker, Rafi Emmanuel, et al.
Nature Nanotechnology|January 31, 2018
A modular platform for targeted RNAi therapeuticsRanit Kedmi, Nuphar Veiga, Srinivas Ramishetti, et al.
Small (Weinheim an Der Bergstrasse, Germany)|June 23, 2025
On-Chip De Novo Production of mRNA Vaccine in Lipid NanoparticlesShai Zilberzwige-Tal, Aviad Levin, Assaf Ezra, et al.
Pageof 19